Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group

被引：1

作者：

Colling, Richard ^{[1
,2
]}

Indave, Iciar ^{[3
]}

Del Aguilla, Javier ^{[3
]}

Jimenez, Ramon Cierco ^{[3
]}

Campbell, Fiona ^{[4
]}

Chechlinska, Magdalena ^{[5
]}

Kowalewska, Magdalena ^{[6
]}

Holdenrieder, Stefan ^{[7
]}

Trulson, Inga ^{[7
]}

Worf, Karolina ^{[7
]}

Pollan, Marina ^{[8
,9
]}

Plans-Beriso, Elena ^{[8
]}

Perez-Gomez, Beatriz ^{[8
,9
]}

Craciun, Oana ^{[8
]}

Garcia-Ovejero, Ester ^{[8
]}

Michalek, Irmina Maria ^{[10
]}

Maslova, Kateryna ^{[5
]}

Rymkiewicz, Grzegorz ^{[10
]}

Didkowska, Joanna ^{[11
]}

Tan, Puay Hoon ^{[12
]}

Nasir, Nur Diyana Bte M. D. ^{[12
]}

Myles, Nickolas ^{[3
]}

Giesen, Christine ^{[3
]}

Goldman-Levy, Gabrielle ^{[3
]}

Lokuhetty, Dilani ^{[3
]}

Cree, Ian A. ^{[3
]}

机构：

[1] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Level 4, Oxford, England

[2] Oxford Univ Hosp NHS FT, Dept Cellular Pathol, Oxford, England

[3] WHO, Int Agcy Res Canc IARC, Lyon, France

[4] Newcastle Univ, Populat Hlth Sci, Newcastle Upon Tyne, England

[5] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Canc Biol, Warsaw, Poland

[6] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Mol & Translat Oncol, Warsaw, Poland

[7] German Heart Ctr Munich, Inst Lab Med, Munich, Germany

[8] Inst Salud Carlos III, Natl Ctr Epidemiol, Madrid, Spain

[9] Consortium Biomed Res Epidemiol & Publ Hlth CIBERE, Madrid, Spain

[10] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Canc Pathomorphol, Warsaw, Poland

[11] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Epidemiol & Canc Prevent, Polish Natl Canc Registry, Warsaw, Poland

[12] Luma Med Ctr, Singapore, Singapore

来源：

MODERN PATHOLOGY | 2024年 / 37卷 / 07期

关键词：

checklist; evidence-based medicine; guidance; guidelines; pathology; reporting; CASE SERIES; COHORT;

D O I：

10.1016/j.modpat.2024.100515

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Evidence-based medicine (EBM) can be an unfamiliar territory for those working in tumor pathology research, and there is a great deal of uncertainty about how to undertake an EBM approach to planning and reporting histopathology-based studies. In this article, reviewed and endorsed by the Word Health Organization International Agency for Research on Cancer 's International Collaboration for Cancer Classi fication and Research, we aim to help pathologists and researchers understand the basics of planning an evidence-based tumor pathology research study, as well as our recommendations on how to report the findings from these. We introduce some basic EBM concepts, a framework for research questions, and thoughts on study design and emphasize the concept of reporting standards. There are many study-speci fic reporting guidelines available, and we provide an overview of these. However, existing reporting guidelines perhaps do not always fi t tumor pathology research papers, and hence, here, we collate the key reporting data set together into one generic checklist that we think will simplify the task for pathologists. The article aims to complement our recent hierarchy of evidence for tumor pathology and glossary of evidence (study) types in tumor pathology. Together, these articles should help any researcher get to grips with the basics of EBM for planning and publishing research in tumor pathology, as well as encourage an improved standard of the reports available to us all in the literature. (c) 2024 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology. This is an open access article under the CC BY license (http://creativecommons.org/ licenses/by/4.0/).

引用

页数：7

共 33 条

[11]

du Sert NP, 2020, J CEREBR BLOOD F MET, V40, P1769, DOI [10.1186/s12917-020-02451-y, 10.1371/journal.pbio.3000410, 10.1177/0271678X20943823]

[12]

Equator Network, Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement

[13]

Equator Network, REportingrecommendations for Tumour MARKerprognostic Studies (REMARK)

[14]

Falci Saulo Gabriel Moreira, 2015, Dental Press J Orthod, V20, P13, DOI 10.1590/2176-9451.20.3.013-015.ebo

[15]

Gagnier JJ, 2013, DTSCH ARZTEBL INT, V110, P603, DOI [10.3238/arztebl.2013.0603, 10.1111/head.12246, 10.1136/bcr-2013-201554, 10.7453/gahmj.2013.008, 10.1186/1752-1947-7-223]

[16]

HRA, Research Registration and Research Project Identifiers

[17]

IARC, 2023, WCT EVI MAP Project Overview

[18]

IARC, About IARC

[19]

ICMJR, Recommendations

[20]

Kendall TJ, 2021, LANCET ONCOL, V22, pE435, DOI 10.1016/S1470-2045(21)00344-2

← 1 2 3 4 →